Tribute Pharmaceuticals Canada Inc.: 10-Q filed 2013-08-13
What Tribute Pharmaceuticals Canada Inc. reported in its quarterly report filed 2013-08-13 (fiscal Q2 2013): 35 published measures, 96 facts as tagged in accession 0001354488-13-004398.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-08-13
- Fiscal period
- fiscal Q2 2013
- Accession
- 0001354488-13-004398 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Tribute Pharmaceuticals Canada Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 19,706,528 | CAD | |
| At 2012-12-31 | 20,828,532 | CAD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 9,047,730 | CAD | |
| At 2012-12-31 | 9,094,408 | CAD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 10,658,798 | CAD | |
| At 2012-12-31 | 11,734,124 | CAD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,320,669 | CAD | |
| At 2012-12-31 | 2,283,868 | CAD | |
| At 2012-06-30 | 3,389,670 | CAD | |
| At 2011-12-31 | 2,227,973 | CAD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -3,702,459 | CAD | 181 |
| 2012-01-01 to 2012-06-30 | -1,357,770 | CAD | 182 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -4,198,793 | CAD | 181 |
| 2012-01-01 to 2012-06-30 | -1,603,711 | CAD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 19,996 | CAD | 181 |
| 2012-01-01 to 2012-06-30 | 15,489 | CAD | 182 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 3,330,047 | CAD | 91 |
| 2013-01-01 to 2013-06-30 | 6,752,227 | CAD | 181 |
| 2012-04-01 to 2012-06-30 | 2,891,062 | CAD | 91 |
| 2012-01-01 to 2012-06-30 | 5,791,216 | CAD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 3,569,904 | CAD | 181 |
| 2012-01-01 to 2012-06-30 | 3,156,066 | CAD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -486,776 | CAD | 181 |
| 2012-01-01 to 2012-06-30 | -457,509 | CAD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | -11,426,015 | CAD | |
| At 2013-03-31 | -10,440,313 | CAD | |
| At 2012-12-31 | -7,723,556 | CAD | |
| At 2012-06-30 | -5,732,360 | CAD | |
| At 2012-03-31 | -5,000,938 | CAD | |
| At 2011-12-31 | -4,374,590 | CAD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 50,972,542 | shares | 91 |
| 2013-01-01 to 2013-06-30 | 45,274,545 | shares | 181 |
| 2012-04-01 to 2012-06-30 | 39,610,042 | shares | 91 |
| 2012-01-01 to 2012-06-30 | 38,719,932 | shares | 182 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 50,972,542 | shares | 91 |
| 2013-01-01 to 2013-06-30 | 45,274,545 | shares | 181 |
| 2012-04-01 to 2012-06-30 | 39,610,042 | shares | 91 |
| 2012-01-01 to 2012-06-30 | 38,719,932 | shares | 182 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,123,668 | CAD | |
| At 2012-12-31 | 1,159,375 | CAD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 289,969 | CAD | 181 |
| 2012-01-01 to 2012-06-30 | 320,423 | CAD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 4,563,410 | CAD | |
| At 2012-12-31 | 5,071,039 | CAD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 80,145 | CAD | 91 |
| 2013-01-01 to 2013-06-30 | 168,003 | CAD | 181 |
| 2012-04-01 to 2012-06-30 | 59,302 | CAD | 91 |
| 2012-01-01 to 2012-06-30 | 60,686 | CAD | 182 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 7,770,043 | CAD | |
| At 2012-12-31 | 6,963,717 | CAD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 3,599,077 | CAD | |
| At 2012-12-31 | 3,599,077 | CAD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,319,285 | CAD | |
| At 2012-12-31 | 1,205,087 | CAD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 2,841,604 | CAD | 91 |
| 2013-01-01 to 2013-06-30 | 6,120,780 | CAD | 181 |
| 2012-04-01 to 2012-06-30 | 2,218,391 | CAD | 91 |
| 2012-01-01 to 2012-06-30 | 4,333,001 | CAD | 182 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,120,935 | CAD | |
| At 2012-12-31 | 1,000,557 | CAD |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -1,491,223 | CAD | 91 |
| 2013-01-01 to 2013-06-30 | -3,167,161 | CAD | 181 |
| 2012-04-01 to 2012-06-30 | -1,263,407 | CAD | 91 |
| 2012-01-01 to 2012-06-30 | -2,496,198 | CAD | 182 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 2,507,117 | CAD | 91 |
| 2013-01-01 to 2013-06-30 | 5,456,721 | CAD | 181 |
| 2012-04-01 to 2012-06-30 | 2,090,965 | CAD | 91 |
| 2012-01-01 to 2012-06-30 | 4,108,538 | CAD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 6,574 | CAD | 91 |
| 2012-01-01 to 2012-06-30 | 8,326 | CAD | 182 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 2,157,692 | CAD | |
| At 2012-12-31 | 1,867,723 | CAD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 2,135,115 | CAD | |
| At 2012-12-31 | 2,115,119 | CAD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,011,447 | CAD | |
| At 2012-12-31 | 955,744 | CAD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 10,364,845 | CAD | |
| At 2012-12-31 | 10,883,179 | CAD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 228,849 | CAD | |
| At 2012-12-31 | 118,910 | CAD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -985,702 | CAD | 91 |
| 2013-01-01 to 2013-06-30 | -3,702,459 | CAD | 181 |
| 2012-04-01 to 2012-06-30 | -731,422 | CAD | 91 |
| 2012-01-01 to 2012-06-30 | -1,357,770 | CAD | 182 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -985,702 | CAD | 91 |
| 2013-01-01 to 2013-06-30 | -3,702,459 | CAD | 181 |
| 2012-04-01 to 2012-06-30 | -731,422 | CAD | 91 |
| 2012-01-01 to 2012-06-30 | -1,357,770 | CAD | 182 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 262,574 | CAD | 91 |
| 2013-01-01 to 2013-06-30 | 525,114 | CAD | 181 |
| 2012-04-01 to 2012-06-30 | 88,912 | CAD | 91 |
| 2012-01-01 to 2012-06-30 | 172,803 | CAD | 182 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -114,198 | CAD | 181 |
| 2012-01-01 to 2012-06-30 | -152,371 | CAD | 182 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -120,378 | CAD | 181 |
| 2012-01-01 to 2012-06-30 | -18,078 | CAD | 182 |
Inspect the source
- Entity
- Tribute Pharmaceuticals Canada Inc. / CIK 0001159019
- Captured
- SEC response SHA-256
580713a84aa79c7c06f7641b783696cf8e0676bb71dd55f93cd67e6d441393a2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001159019.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))